Professional Bio
Christine M. Lovly, MD, PhD, is an Associate Professor of Medicine with tenure in the Division of Hematology and Oncology, Department of Medicine, at Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center.
She received a BA in chemistry from Johns Hopkins University followed by MD and PhD degrees as part of the Medical Scientist Training Program at Washington University in St. Louis. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O'Hare Chief Fellow. She started on faculty at Vanderbilt in 2013 as a physician scientist, splitting her time between clinical care and laboratory research. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer.
Dr. Lovly has received grant funding from NIH/NCI, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Sarcoma Foundation of America, the American Cancer Society, the Damon Runyon foundation, the LUNGevity foundation, the V Foundation, the American Association for Cancer Research, and Lung Cancer Foundation of America / International Association for the Study of Lung Cancer. She is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). Her team's work has published in high impact journals, including Cancer Discovery, Nature Medicine, Nature Communications, Journal of Clinical Oncology, and others.
Dr. Lovly is also an elected member of the American Society for Clinical Investigation (ASCI) and a member of the Editorial Board for Cancer Discovery and JCO Precision Oncology. She serves on the Scientific Leadership Boards for the GO2 Foundation for Lung Cancer Research (where she also serves as Scientific Leadership Board director), the LUNGevity Foundation, and the Lung Cancer Research Foundation. She serves several roles within AACR, including being an invited member of the Science Policy and Government Affairs committee and s chair of the AACR Tobacco Products and Cancer Subcommittee. She serves on the National Comprehensive Cancer Network (NCCN) guidelines panel for Non-Small Cell Lung Cancer and is co-chair of the ECOG-ACRIN Thoracic Translational Science Center Lung Biology Committee.
In 2021, Dr. Lovly was awarded the ECOG-ACRIN Cancer Research Group Young Investigator Award. In 2022, she was awarded the GO2 Foundation Asclepios Award honoring research pioneers in the fight to end lung cancer.
Relevant Links
Publications
Education
Fellowship - Hematology & Oncology - Vanderbilt University
PhD - Washington University in St. Louis, 2006
MD - Washington University in St. Louis, 2006
Residency - IM - Vanderbilt University, 2008
Fellowship - Hematology - Vanderbilt University, 2010
Fellowship - Clinical - HO - Vanderbilt University, 2011
Fellowship - Chief - HO - Vanderbilt University, 2012
Contact
Email
Kimryn.Rathmell@Vumc.Org
Address
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307